XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Restricted Stock (Tables)
3 Months Ended
Mar. 31, 2024
Stock Options and Restricted Stock  
Summary of the status of the Company's outstanding stock options

The fair value of each option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model. The following table presents a summary of the status of the Company’s outstanding stock options for the three months ended March 31, 2024:

March 31, 2024

    

    

    

Weighted

Average

Shares

Exercise Price

Outstanding at Beginning of Year

 

2,014,994

$

10.57

Granted

 

 

Exercised

 

(8,000)

 

8.28

Forfeitures

 

(5,000)

 

11.10

Outstanding at Period End

 

2,001,994

$

10.58

Options Exercisable at Period End

 

1,421,494

$

9.80

Summary of information pertaining to options outstanding based on range of exercise price

The following table presents information pertaining to options outstanding at March 31, 2024:

Options Outstanding

Options Exercisable

Weighted Average

Number of

Weighted Average

Remaining Contractual

Number of

Weighted Average

Range of Exercise Prices

    

Options

    

Exercise Price

Life in Years

Options

    

Exercise Price

$

3.00 - 3.99

 

10,000

$

3.58

0.8

 

10,000

 

$

3.58

7.00 - 7.99

 

888,966

 

7.47

 

3.5

 

888,966

 

7.47

8.00 - 8.99

 

12,500

 

8.76

 

6.0

 

6,250

 

8.76

10.00 - 10.99

249,000

10.63

9.2

7,500

10.08

11.00 - 11.99

262,500

11.15

8.2

75,000

11.29

12.00 - 12.99

263,528

12.90

5.3

263,528

12.90

13.00 - 13.99

25,000

13.22

4.1

25,000

13.22

17.00 - 17.99

290,500

17.50

7.8

145,250

17.50

Totals

 

2,001,994

$

10.58

5.7

 

1,421,494

$

9.80

Summary of analysis of nonvested options to purchase shares of the Company's stock issued and outstanding

The following table presents an analysis of nonvested options to purchase shares of the Company’s stock issued and outstanding for the three months ended March 31, 2024:

    

    

    

Weighted

Number of

Average Grant

Shares

Date Fair Value

Nonvested Options at December 31, 2023

 

666,250

$

5.09

Granted

 

Vested

 

(80,750)

5.05

Forfeited

(5,000)

4.58

Nonvested Options at March 31, 2024

 

580,500

$

5.10

Summary of the status of the Company's outstanding restricted stock awards

The following table presents an analysis of nonvested restricted stock awards outstanding for the three months ended March 31, 2024:

    

    

    

Weighted

Number of

Average Grant

Shares

Date Fair Value

Nonvested at December 31, 2023

 

3,411

$

10.53

Granted

 

Vested

 

(987)

12.67

Forfeited

Nonvested at March 31, 2024

 

2,424

$

9.66

Summary of the status of the Company's outstanding restricted stock units

The following table presents an analysis of nonvested restricted stock units outstanding for the three months ended March 31, 2024:

    

    

    

Weighted

Number of

Average Grant

Units

Date Fair Value

Nonvested at December 31, 2023

 

441,015

$

14.71

Granted

 

63,184

11.89

Vested

 

(22,365)

15.60

Forfeited

(10,276)

14.75

Nonvested at March 31, 2024

 

471,558

$

14.29